ROCHESTER, Minn. -- Mayo Clinic researchers working in concert with other North Central Cancer Treatment Group (NCCTG) investigators have found that administering epoetin alfa for anemia once every three weeks to patients with anemia and cancer, instead of the traditional weekly epoetin treatments, maintains similar levels of red blood cells. Results of the study are available online in the Journal of Clinical Oncology.

Anemia is a common complication of cancer and can significantly impair a patient's quality of life, causing tiredness, shortness of breath, dizziness and other problems. Epoetin alfa stimulates bone marrow production of blood cells, thereby reducing anemia. "We are constantly looking for ways to make treatments easier for patients," says David Steensma, M.D., Mayo Clinic oncologist and lead author of the study. "Sometimes this means finding ways to treat side effects. In this case we studied how to treat a side effect without sacrificing as much of the patient's time and money."

Dr. Steensma and his team studied 360 patients who were randomly assigned to receive either the standard protocol of 40,000 units (40K) of epoetin alfa once a week for 21 weeks, or 40K units of epoetin alfa once a week for three weeks followed by 120,000 units (120K) of epoetin alfa once every three weeks for the remaining 18 weeks. The investigators found no statistical difference in the proportion of patients requiring transfusions due to low hemoglobin between the groups. Side effects, including thromboembolism (blood clot in a blood vessel) and overall survival also were similar. Hemoglobin levels were slightly greater throughout the study for the patients enrolled in the 40K group, but those receiving 120K every three weeks still maintained a level that did not require transfusions. At the end of the study, patients in each group reported a similar quality of life.

While they find the results of this study promising, Dr. Steensma and hi
'"/>


27-Feb-2006

Page: 1 2
Related medicine news :

1. Fine as North Dakota wine
2. Northwestern chemists develop new method for synthesizing anti-cancer flavonoids
3. $15M Northwestern grant funds heart research
4. Northwestern surgeon invents teaching technology for scary patient exams
5. 46-year-old man receives first temporary total artificial heart in Northeast US from Penn
6. Surveys find outright hunger among Latino immigrants in North Carolina
7. Africans much better than North Americans at taking anti-HIV meds
8. Media alert: Register now for the largest obesity conference in North America
9. Northwestern Memorial earns magnet status for nursing excellence
10. Heart transplant program at Northwestern Memorial Hospital celebrates anniversary
11. Skin disease common among Hispanic farmworkers in North Carolina, research shows